ABSTRACT
Purpose
To investigate the dehydration of carbamazepine dihydrate, combining kinetics and crystal water dynamics with electronic structure calculations.
Methods
Thermal microscopy, moisture sorption, and thermogravimetric analysis (TGA) were applied to evaluate the effects on relative humidity (RH) and temperature, while crystal water dynamics were monitored by 2D-FTIR correlation spectroscopy (2DCOS) and the nature of the H-bonding network was investigated by 3D-periodic DFT calculations.
Results
It was found that the dihydrate is unstable below 40% RH and/or above the glass transition temperature (T g ∼ 53°C). At room temperature, amorphous carbamazepine is formed at RH ∼ 0%, form I at RH ∼ 10%, and mixtures of forms I and III at higher RH. Above the T g , the dehydration yields partially crystalline mixtures of forms I and IV between 50–100°C, and form I above 100°C. In all cases, the amorphous product crystallizes to form IV. Thermal analysis and 2DCOS revealed a biphasic dehydration process. Kinetic modelling suggests a diffusion-controlled dehydration below T g and reaction interface-controlled kinetics above T g .
Conclusions
The dehydration consists of two overlapping water removal processes, with the water molecule attached to the amide C=O departing faster, probably due to the destabilizing effect of anti-bonding interactions between the water H1s and the carbonyl O2p orbital.
Similar content being viewed by others
REFERENCES
Khankari R, Grant DJW. Pharmaceutical hydrates. Thermochim Acta. 1995;248:61–79.
Giron D, Goldbronn C, Mutz M, Pfeffer S, Piechon P, Schwab P. Solid state characterizations of pharmaceutical hydrates. J Thermal Anal Calorim. 2002;68:453–65.
Petit S, Coquerel G. Mechanism of several solid-solid transformations between dihydrated and anhydrous copper(II) 8-hydroxyquinolinates. Proposition for a unified model for the dehydration of molecular crystals. Chem Mater. 1996;8:2247–58.
Galwey AK. Structure and order in thermal dehydrations of crystalline solids. Thermochim Acta. 2000;355:181–238.
Jørgensen A, Strachan C, Pöllänen K, Koradia V, Tian F, Rantanen J. An insight into water of crystallization during processing using vibrational spectroscopy. J Pharm Sci. 2009;98:3903–32.
Beard M, Ghita O, McCabe J, Evans K. Monitoring dehydration kinetics using simultaneous thermal and spectral methods. J Raman Spectrosc. 2010;41:1283–8.
Agbada C, York P. Dehydration of theophylline monohydrate powder – effects of particle size and sample weight. Int J Pharm. 1994;106:33–40.
Sheth A, Zhou D, Muller F, Grant DJW. Dehydration kinetics of piroxicam monohydrate and relationship to lattice energy and structure. J Pharm Sci. 2004;93:3013–26.
Han J, Suryanarayanan R. Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate. Pharm Dev Technol. 1998;3:587–96.
Yoneda S, Sugawara Y, Urabe H. Crystal water dynamics of guanosine dihydrate: analysis of atomic displacement parameters, time profile of hydrogen-bonding probability, and translocation of water by MD simulation. J Phys Chem B. 2005;109:1304–12.
Grzesiak A, Lang M, Kim K, Matzger A. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci. 2003;92:2260–71.
Reck G, Dietz G. The order–disorder structure of carbamazepine dihydrate: 5 H-dibenz[b, f]azepine-5-carboxamide dihydrate, C15H12N2O.2H2O. Cryst Res Technol. 1986;21:1463–8.
Fleischman S, Kuduva S, McMahon J, Moulton B, Bailey Walsh R, Rodriguez-Hornedo N, Zaworotko M. Crystal engineering of the composition of pharmaceutical phases: multiple-component crystalline solids involving carbamazepine. Cryst Growth Des. 2003;3:909–19.
Meyer M, Straughn A, Jarvi E, Wood G, Pelsor F, Shah V. The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharm Res. 1992;9:1612–6.
Kobayashi Y, Ito S, Itai S, Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int J Pharm. 2000;193:137–46.
Harris R, Ghi P, Puschmann H, Apperley D, Griesser UJ, Hammond R, Ma C, Roberts K, Pearce G, Yates J, Pickard C. Structural studies of the polymorphs of carbamazepine, its dihydrate, and two solvates. Org Process Res Dev. 2005;9:902–10.
Gelbrich T, Hurtshouse M. Systematic investigation of the relationships between 25 crystal structures containing the carbamazepine molecule or a close analogue: a case study of the XPac method. Cryst Eng Comm. 2006;8:448–60.
Kogan A, Popov I, Uvarov V, Cohen S, Aserin A, Garti N. Crystallization of carbamazepine pseudopolymorphs from nonionic microemulsions. Langmuir. 2008;24:722–33.
Dugue J, Ceolin R, Rouland JC, Lepage F. Polymorphism of carbamazepine-solid state studies. Pham Acta Helv. 1991;66:307–10.
Griesser UJ. Untersuchungen zur Polymorphie und Pseudopolymorphie von Arzneistoffen de Pharmacopoea Europaea unter besondered Berücksichtigung wasserhaltiger Kristallformen. Dissertation, University of Innsbruck. 1991.
Li Y, Han J, Zhang G, Grant D, Suryanarayanan R. In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine. Pharm Devel Technol. 2000;5:257–66.
Surana R, Pyne A, Suryanarayanan R. Solid-vapor interactions: influence of environmental conditions on the dehydration of carbamazepine dihydrate. Pharm Sci Tech. 2003;4:1–10.
Murphy D, Rodríguez-Cintrón F, Langevin B, Kelly RC, Rodríguez-Hornedo N. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int J Pharm. 2002;246:121–34.
Kogermann K, Aaltonen J, Strachan C, Pöllänen K, Veski P, Heinämäki J, Yliruusi J, Rantanen J. Qualitative in situ analysis of multiple solid-state forms using spectroscopy and partial least squares discriminant modeling. J Pharm Sci. 2007;96:1802–20.
McMahon L, Timmins P, Williams A, York P. Characterization of dihydrates prepared from carbamazepine polymorphs. J Pharm Sci. 1996;85:1064–9.
Otsuka M, Ofusa T, Matsuda Y. Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding. Colloids Surf B Biointerfaces. 1999;13:163–273.
Fleming S, Rohl A. GDIS: a visualization program for molecular and periodic systems. Z Kristallogr. 2005;220:580–4.
Gale J, Rohl A. The General Utility Lattice Program (GULP). Molec Sim. 2003;29:291–341.
Mayo S, Olafson B, Goddard III W. DREIDING: a generic force field for molecular simulations. J Phys Chem. 1990;94:8897–909.
Jakalian A, Bush B, Jack D, Bayly C. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method. J Comput Chem. 2000;21:132–46.
Jakalian A, Jack D, Bayly C. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parametrization and validation. J Comput Chem. 2000;23:1623–41.
Eyring H. The activated complex in chemical reactions. J Chem Phys. 1935;3:107–15.
Noda I. Two-dimensional infrared (2D IR) spectroscopy: theory and applications. Appl Spectrosc. 1990;44:550–61.
Troullier N, Martins JL. Efficient pseudopotentials for plane-wave calculations. Phys Rev B. 1991;43:1993–2006.
Dion M, Rydberg H, Schröder E, Langreth D, Lundqvist B. Van der Waals density functional for general geometries. Phys Rev Lett. 2004;92:1–4.
Dronskowski R, Bloechl P. Crystal orbital Hamilton populations (COHP): energy-resolved visualization of chemical bonding in solids based on density-functional calculations. J Phys Chem. 1993;97:8617–24.
Soler JM, Artacho E, Gale J, García A, Junquera J, Ordejón P, Sánchez-Portal D. The SIESTA method for ab initio order-N materials simulation. J Phys Condens Matter. 2002;14:2745–79.
Griesser UJ. The importance of solvates. In: Hilfiker R, editor. Polymorphism in the pharmaceutical industry. Weinheim: Wiley-VCH; 2006. p. 224.
Brown M, Galwey AK, Guarini G. Structures and functions of reaction interfaces developed during solid-state dehydrations. J Thermal Anal. 1997;49:1135–46.
Chizhik S, Sidel’nikov A. Kinetics of solid state reactions with a positive feedback between the reaction and fracture: 1. A quantitative model for movement of the fracture front. Russ Chem Bull. 1998;47:604–9.
Khoo JY, Williams D, Heng J. Dehydration kinetics of pharmaceutical hydrate: effects of environmental conditions and crystal forms. Dry Technol. 2010;28:1164–9.
Patterson J, James M, Forster A, Lancaster R, Butler J, Rades T. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. J Pharm Sci. 2005;94:1998–2012.
Gillon A, Feeder N, Davey R, Storey R. Hydration in molecular crystals – a Cambridge Structural Database analysis. Cryst Growth Des. 2003;3:663–73.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kachrimanis, K., Griesser, U.J. Dehydration Kinetics and Crystal Water Dynamics of Carbamazepine Dihydrate. Pharm Res 29, 1143–1157 (2012). https://doi.org/10.1007/s11095-012-0698-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-012-0698-4